Innovate Biopharmaceuticals Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease Pharmaceutical Investing
Atara Biotherapeutics Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma Pharmaceutical Investing
Life Science Big News Roundup: NanoSphere Forms Strategic Partnership in Mexico; Chemesis International Inc. Announces Approval of OTCQB Uplisting Life Science Investing News
Idera Pharmaceuticals Presents Clinical Safety and Efficacy Update from the ILLUMINATE-204 Trial Life Science Investing News
